DE FERRARI, GAETANO
 Distribuzione geografica
Continente #
NA - Nord America 8.350
AS - Asia 5.651
EU - Europa 3.794
SA - Sud America 1.148
Continente sconosciuto - Info sul continente non disponibili 338
AF - Africa 199
OC - Oceania 8
Totale 19.488
Nazione #
US - Stati Uniti d'America 7.945
CN - Cina 2.862
SG - Singapore 1.128
IE - Irlanda 1.031
BR - Brasile 873
VN - Vietnam 621
IT - Italia 524
HK - Hong Kong 472
RU - Federazione Russa 468
DE - Germania 436
FI - Finlandia 358
UA - Ucraina 236
FR - Francia 232
CA - Canada 190
GB - Regno Unito 176
IN - India 129
SE - Svezia 113
AR - Argentina 106
ZA - Sudafrica 95
BD - Bangladesh 70
AT - Austria 63
MX - Messico 52
ID - Indonesia 48
EC - Ecuador 46
IQ - Iraq 46
PK - Pakistan 41
CO - Colombia 40
JP - Giappone 39
PL - Polonia 32
VE - Venezuela 28
NL - Olanda 24
TR - Turchia 24
JM - Giamaica 23
PY - Paraguay 23
IL - Israele 22
BE - Belgio 21
ES - Italia 21
MY - Malesia 21
CR - Costa Rica 19
MA - Marocco 19
TT - Trinidad e Tobago 19
SA - Arabia Saudita 18
KE - Kenya 17
SV - El Salvador 17
PR - Porto Rico 16
CL - Cile 15
GP - Guadalupe 15
HN - Honduras 15
UZ - Uzbekistan 15
CW - ???statistics.table.value.countryCode.CW??? 14
EG - Egitto 14
GT - Guatemala 13
NI - Nicaragua 12
PH - Filippine 12
TN - Tunisia 12
AE - Emirati Arabi Uniti 10
DZ - Algeria 9
JO - Giordania 9
AL - Albania 8
AZ - Azerbaigian 8
AU - Australia 7
SC - Seychelles 7
UY - Uruguay 7
PE - Perù 6
TH - Thailandia 6
BG - Bulgaria 5
KZ - Kazakistan 5
MU - Mauritius 5
PS - Palestinian Territory 5
PT - Portogallo 5
RO - Romania 5
AO - Angola 4
BH - Bahrain 4
CH - Svizzera 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
KW - Kuwait 4
LT - Lituania 4
NP - Nepal 4
QA - Qatar 4
BA - Bosnia-Erzegovina 3
BB - Barbados 3
CZ - Repubblica Ceca 3
EU - Europa 3
GE - Georgia 3
GR - Grecia 3
IR - Iran 3
KR - Corea 3
LB - Libano 3
LV - Lettonia 3
OM - Oman 3
BW - Botswana 2
CG - Congo 2
CI - Costa d'Avorio 2
CY - Cipro 2
EE - Estonia 2
ET - Etiopia 2
HU - Ungheria 2
MN - Mongolia 2
MQ - Martinica 2
Totale 19.135
Città #
Dublin 1.028
Ashburn 783
Chandler 746
San Jose 742
Nanjing 655
Jacksonville 598
Dallas 553
Singapore 544
Council Bluffs 478
Hong Kong 460
Beijing 434
Nanchang 261
Boardman 247
Ho Chi Minh City 220
Princeton 206
Lawrence 198
Medford 190
Changsha 187
Lauterbourg 177
Wilmington 177
Shenyang 174
Los Angeles 169
Helsinki 162
Hebei 155
Hanoi 154
Jiaxing 145
New York 134
Munich 121
Hangzhou 112
Tianjin 106
Buffalo 95
Moscow 89
São Paulo 88
Pavia 79
Ann Arbor 77
Johannesburg 73
Redondo Beach 72
Santa Clara 66
Milan 60
Shanghai 60
Nuremberg 54
Mcallen 52
Orem 43
Atlanta 42
Norwalk 41
Montréal 37
Tokyo 36
Fairfield 34
Dearborn 33
Montreal 33
Woodbridge 33
Frankfurt am Main 30
Vienna 30
Rio de Janeiro 28
Guangzhou 27
Rome 27
Warsaw 27
Brooklyn 26
Chicago 26
Toronto 26
Turku 25
Haiphong 24
Phoenix 23
Seattle 23
Chennai 21
Denver 21
Da Nang 20
Ottawa 20
Biên Hòa 19
Brasília 19
Curitiba 19
San Francisco 19
Baghdad 18
Bari 18
San José 18
Verona 18
Brussels 17
Columbus 17
Jinan 17
Joinville 17
Mexico City 17
Houston 16
Philadelphia 16
Stockholm 16
Des Moines 15
Queens 15
Quito 15
Zhengzhou 15
Guayaquil 14
Jakarta 14
Kingston 14
Naples 14
Pune 14
Redwood City 14
Tashkent 14
Buenos Aires 13
Mumbai 13
Willemstad 13
Dhaka 12
London 12
Totale 12.439
Nome #
Identificazione di microRNA circolanti specificatamente sovra espressi in corso di infarto miocardico acuto. 276
Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions. 264
Pathophysiological rationale for cardiac vagal denervation in the treatment of atrial fibrillation 187
Amiodarone 180
Antidepressants: their effects on cardiac channels, QT prolongation and Torsade de Pointes 177
A challenging case of permanent junctional reciprocating tachycardia (pjrt) in post-partum cardiogenic shock 157
Closure of patent foramen ovale or medical therapy alone for secondary prevention of cryptogenic cerebrovascular events 156
Past and future of the "Pavia eCPR program" 150
PREDESTINATION: PRimary vEntricular fibrillation and suDden dEath during a firST myocardIal iNfArcTION: Genetic basis. 148
Gene symbol: KCNH2 146
Comparison of Outcomes of Staged Complete Revascularization Versus Culprit Lesion–Only Revascularization for ST-Elevation Myocardial Infarction and Multivessel Coronary Artery Disease 143
Atrial arrhythmias prevalence in heart transplant patients. 140
Clinical governance programme in patients with acute coronary syndrome: Design and methodology of a quality improvement initiative 138
Patient Outcomes With STEMI Caused by Aneurysmal Coronary Artery Disease and Treated With Primary PCI 137
[Vagus nerve stimulation for the treatment of heart failure] 135
Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. 134
Remote ischemic postconditioning as a strategy to reduce acute kidney injury during primary PCI: A post-hoc analysis of a randomized trial 132
Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions: Insights from the EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in Italian cardiac care units Registry 132
Elevated serum uric acid affects myocardial reperfusion and infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention 131
Amiodarone in the treatment of Atrial Fibrillation: New Perspectives from Clinical Trials 130
Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients with Stable Ischemic Heart Disease and Previous Myocardial Infarction 128
Efficacy versus safety: The dilemma of using novel platelet inhibitors for the treatment of patients with ischemic stroke and coronary artery disease 128
Angiography- versus physiology-guided complete revascularization in patients with STEMI and multivessel disease: who's the better gatekeeper in this setting? 128
[Baroceptive reflex sensibility in non-anesthetized animals. Evaluation and comparison of 2 methods applicable to humans]. 126
Smoker's paradox in ST-elevation myocardial infarction: Role of inflammation and platelets 126
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes 125
Prognostic Impact of in-Hospital-Bleeding in Patients With ST-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention 123
Favorable effect of glycoprotein IIbIIIa inhibitors among STEMI patients treated with primary PCI and incomplete ST resolution 123
Strategies for reducing door to balloon time in patients with acute myocardial infarction undergoing primary angioplasty: the Pavia experience 123
Successful repair of lateral wall pseudoaneurysm via left anterior minithoracotomy using port-access tecnique 122
Drug eluting stents are superior to bare metal stents to reduce clinical outcome and stent-related complications in CKD patients, a systematic review, meta-analysis and network meta-analysis 122
Acute Kidney Injury Definition and In-Hospital Mortality in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction 121
Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease: An Analysis from FOURIER. 121
Ranolazine in the treatment of atrial fibrillation: Results of the dose-ranging RAFFAELLO (ranolazine in atrial fibrillation following an electrical cardioversion) study 121
[Sudden death after myocardial infarction. Prediction based on the baroreceptor reflex]. 120
The prognostic value of late gadolinium enhancement in hypertrophic cardiomyopathy: An updated meta-analysis 120
KCNH2-K897T Is a Genetic Modifier of Latent Congenital Long-QT Syndrome. 119
Thromboembolism after atrioventricular node ablation and pacing: long term follow up. 118
Baroreflex sensitivity predicts long-term cardiovascular mortality after myocardial infarction even in patients with preserved left ventricular function. 117
Atrial fibrillation requiring urgent medical care. Approach and outcome in the various departments of admission. Data from the atrial Fibrillation/flutter Italian REgistry (FIRE). 117
Atrial fibrillation in heart failure patients: prevalence in daily practice and effect on the severity of symptoms. Data from the ALPHA study registry. 116
Autonomic Modulation for the Management of Patients with Chronic Heart Failure 116
Autonomic nervous system, myocardial ischemia, and malignant ventricular arrhythmias: Experimental findings 115
End-tidal carbon dioxide and defibrillation success in out-of-hospital cardiac arrest 115
Baroreceptor reflexes and sudden cardiac death: experimental findings and background. 114
Dual versus triple therapy in patients on oral anticoagulants and undergoing coronary stent implantation: A systematic review and meta-analysis 114
KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome. 113
Autonomic nervous system and arrhythmias. 112
Scopolamine increases vagal tone and vagal reflexes in patients after myocardial infarction 111
Scopolamine increases vagal tone and vagal reflexes in patients after myocardial infarction. 110
Bortezomib-induced cardiogenic shock in a multiple myeloma patient with K light-chain cardiac amyloidosis 108
Arterial baroreflexes and ventricular tachycardia. 107
Risk factors for primary ventricular fibrillation during a first myocardial infarction: Clinical findings from PREDESTINATION (PRimary vEntricular fibrillation and suDden dEath during firST myocardIal iNfArcTION) 107
Response to Letters Regarding Article, "Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation" 106
Leptin affects the inflammatory response after STEMI 106
Torsades de Pointes following Acute Myocardial Infarction: Evidence for a Deadly Link with a Common Genetic Variant. 105
Clinical management of catecholaminergic polymorphic ventricular tachycardia the role of left cardiac sympathetic denervation 105
Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial 105
Has hyperglycemia a different prognostic role in STEMI patients with or without diabetes? 105
Hospital survival and long term quality of life after emergency institution of venoarterial ECMO for refractory circulatory collapse. 104
Effects of Intra-Aortic Balloon Pump on Markers of Right Ventricular Dysfunction Among End-Stage Heart Failure Patients Candidates to Cardiac Transplant or Ventricular Assist Device 103
Rapid recovery of baroreceptor reflexes in acute myocardial infarction is a marker of effective tissue reperfusion 103
Vagal activity and ventricular fibrillation 103
Pharmacologic modulation of the autonomic nervous system in the prevention of sudden cardiac death. A study with propranolol, methacholine and oxotremorine in conscious dogs with a healed myocardial infarction. 102
Protective effect of vagal stimulation on reperfusion arrhythmias in cats. 102
A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study 102
Primum non nocere: An updated meta-analysis on aspirin use in primary prevention of cardiovascular disease in patients with diabetes 102
Autonomic reflexes and ventricular tachycardia. 101
Early Complete Revascularization in Hemodynamically Stable Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease 101
Neutrophil to platelet ratio: a novel prognostic biomarker in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention 101
Gene symbol: SCN5A 100
Extracorporeal membrane oxigenation support decreases mortality in acute myocardial infarction complicated by refractory cardiogenic shock 100
Left cardiac sympathetic denervation for the prevention of life-threatening arrhythmias: the surgical supraclavicular approach to cervicothoracic sympathectomy 99
Significant left ventricular reverse remodelling following radiofrequency ablation of monomorphic ventricular ectopy in pts with idiopathic cardiomyopathy 98
Left cardiac sympathetic denervation for the prevention of life-threatening arrhythmias: the surgical supraclavicular approach to cervicothoracic sympathectomy. 98
Chemokines and Heart Disease: A Network Connecting Cardiovascular Biology to Immune and Autonomic Nervous Systems 97
Clinical neurocardiology defining the value of neuroscience-based cardiovascular therapeutics. 96
Calmodulin mutations associated with recurrent cardiac arrest in infants. 96
Sympathetic-parasympathetic interaction and accentuated antagonism in conscious dogs 95
Identification of upregulated microRNAs in the plasma of patients with acute myocardial infarction 95
Protective effect of vagal hyperactivity on reperfusion arrhythmias 94
Gene symbol: KCNH2 93
Comparison of antithrombotic strategies in patients with cryptogenic stroke and patent foramen ovale: an updated meta-analysis 93
Sympathetic-parasympathetic interaction in health and disease: abnormalities and relevance in heart failure. 92
I blocchi atrioventricolari. Meccanismi e trattamento 92
QT interval prolongation related to psychoactive drug treatment: a comparison of monotherapy versus polytherapy. 92
The Common Long QT Syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: toward a mutation-specific risk stratification. 91
Impaired baroreflex sensitivity is correlated with hemodynamic deterioration of sustained ventricular tachycardia. 91
Prevalenza della aritmie atriali nei pazienti sottoposti a trapianto cardiaco ortotopico secondo la tecnica di Lower e Shumway 91
Chronic vagus nerve stimulation (CVNS) – A new target for treatment of congestive heart failure. 91
Derivation and validation of the incomplete ST-segment resolution score and its usefulness for treatment with glycoprotein IIb-IIIa inhibitors 90
High-dose erythropoietin in patients with acute myocardial infarction: a pilot, randomised, placebo-controlled study. 90
Two-to-one AV block associated with the congenital long QT syndrome. 90
Use of extracorporeal membrane oxygenation in primary refractory cardiac shock and cardiac arrest; a single centre experience 90
The ALPHA study (T-wave alternans in patients with heart failure): rationale, design and endpoints. 90
Letter by Ferrari et al regarding article, "long-term arrhythmia-free survival in patients with severe left ventricular dysfunction and no inducible ventricular tachycardia after myocardial infarction" 90
Prevalence and features of incessant atrial arrhythmias after heart transplantation with standard technique. 89
IntErnationaL eLeCTRicAl storm registry (ELECTRA): Background, rationale, study design, and expected results 89
Prevention of life-threatening arrhythmias by pharmacologic stimulation of the muscarinic receptors with oxotremorine. 88
Beneficial Effects of IABP in Anterior Myocardial Infarction Complicated by Cardiogenic Shock 87
Totale 11.642
Categoria #
all - tutte 86.061
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.061


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022752 0 0 0 0 5 27 9 51 46 16 121 477
2022/20232.402 306 164 22 153 197 216 2 105 1.154 15 48 20
2023/2024898 54 258 24 56 62 248 34 59 6 32 41 24
2024/20252.288 56 236 57 54 37 72 107 151 629 75 242 572
2025/20266.807 479 618 1.007 1.019 748 271 1.068 263 502 456 235 141
2026/20272.013 100 333 420 712 448 0 0 0 0 0 0 0
Totale 19.488